846 patients shows that paclitaxel-based HIPEC offers comparable survival and lower toxicity, making it a safe alternative to cisplatin in ovarian cancer.
Prof. Dr. Mustafa Özdoğan
HIPEC in Ovarian Cancer: Paclitaxel or Cisplatin for Heated Intraperitoneal Chemotherapy?
Prof. Dr. Mustafa Özdoğan
HIPEC in Ovarian Cancer: Paclitaxel or Cisplatin for Heated Intraperitoneal Chemotherapy?
Yorumlar
Yorum Gönder